The federal government has agreed to purchase 105 million doses of Pfizer-BioNTech’s rebooted vaccine for $3.2 billion, the Washington Post reported on Friday. At $30.50 a dose, that’s a premium over the initial contracts the government made for the original vaccine in 2020, when the vaccines were $19.50 per dose. the government is expected to sign a new contract with Moderna (MRNA) shortly.
Both companies are deep in discussions with the government about a reformulated booster that would add components from the Omicron variants BA.4 and BA.5 to the original vaccine.
The Biden administration is hoping that Moderna, Pfizer, and BioNTech will be able to make the updated doses available in volume as early as mid-September.
Pfizer (PFE) is a member of my Dividend Portfolio. The shares are up 35.14% since I added them to the portfolio on August 28, 2020. The stock is down 11.89% year-to-date for 2022 as of the close on Friday, July 22. However, they are up 4.40% in the last month.
Pfizer pays a 3.12% dividend.
